We serve Chemical Name:(4-bromo-3-methyl-phenyl)-hydrazine CAS:90284-70-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(4-bromo-3-methyl-phenyl)-hydrazine
CAS.NO:90284-70-1
Synonyms:(4-bromo-3-methyl-phenyl)-hydrazine
Molecular Formula:C7H9BrN2
Molecular Weight:201.06400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:38.05000
Exact Mass:199.99500
LogP:2.81640
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (4-bromo-3-methyl-phenyl)-hydrazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4-bromo-3-methyl-phenyl)-hydrazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(4-bromo-3-methyl-phenyl)-hydrazine Use and application,(4-bromo-3-methyl-phenyl)-hydrazine technical grade,usp/ep/jp grade.
Related News: Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions. (4-bromo-3-methyl-phenyl)-hydrazine manufacturer The company reported that it was cooperating with the Justice Department probe and that an outside law firm was also “investigating these allegations thoroughly.” (4-bromo-3-methyl-phenyl)-hydrazine supplier The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association. (4-bromo-3-methyl-phenyl)-hydrazine vendor The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association. (4-bromo-3-methyl-phenyl)-hydrazine factory The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association.